HUE063599T2 - Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére - Google Patents

Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére

Info

Publication number
HUE063599T2
HUE063599T2 HUE19172643A HUE19172643A HUE063599T2 HU E063599 T2 HUE063599 T2 HU E063599T2 HU E19172643 A HUE19172643 A HU E19172643A HU E19172643 A HUE19172643 A HU E19172643A HU E063599 T2 HUE063599 T2 HU E063599T2
Authority
HU
Hungary
Prior art keywords
procedures
treating
reducing
fibrosclerotic panniculopathy
edematous fibrosclerotic
Prior art date
Application number
HUE19172643A
Other languages
English (en)
Hungarian (hu)
Inventor
Susan Hart
Original Assignee
Endo Global Ventures
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Global Ventures filed Critical Endo Global Ventures
Publication of HUE063599T2 publication Critical patent/HUE063599T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE19172643A 2011-10-21 2012-10-19 Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére HUE063599T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161549863P 2011-10-21 2011-10-21

Publications (1)

Publication Number Publication Date
HUE063599T2 true HUE063599T2 (hu) 2024-01-28

Family

ID=48141393

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE19172643A HUE063599T2 (hu) 2011-10-21 2012-10-19 Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére
HUE12842537 HUE044650T2 (hu) 2011-10-21 2012-10-19 Eljárás EFP kezelésére vagy csökkentésére

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE12842537 HUE044650T2 (hu) 2011-10-21 2012-10-19 Eljárás EFP kezelésére vagy csökkentésére

Country Status (14)

Country Link
US (2) US20140335072A1 (cg-RX-API-DMAC7.html)
EP (2) EP3581199B1 (cg-RX-API-DMAC7.html)
JP (5) JP2014530873A (cg-RX-API-DMAC7.html)
AU (6) AU2012325941A1 (cg-RX-API-DMAC7.html)
BR (1) BR112014009785B1 (cg-RX-API-DMAC7.html)
CA (1) CA2852942C (cg-RX-API-DMAC7.html)
DK (2) DK2768523T3 (cg-RX-API-DMAC7.html)
ES (2) ES2953560T3 (cg-RX-API-DMAC7.html)
FI (1) FI3581199T3 (cg-RX-API-DMAC7.html)
HU (2) HUE063599T2 (cg-RX-API-DMAC7.html)
MX (2) MX2014004792A (cg-RX-API-DMAC7.html)
PL (1) PL3581199T3 (cg-RX-API-DMAC7.html)
PT (2) PT2768523T (cg-RX-API-DMAC7.html)
WO (1) WO2013059619A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
EP2844276B1 (en) 2012-05-01 2019-10-02 Proteolease Ltd. Methods for extracting a tooth
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) * 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
AU2018244426B2 (en) 2017-03-28 2024-09-19 Endo Ventures Limited Improved method of producing collagenase
WO2020021330A2 (en) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021332A2 (en) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020023406A1 (en) * 2018-07-23 2020-01-30 Nc8, Inc. Cellulite treatment system and methods
WO2020058755A1 (en) * 2018-09-18 2020-03-26 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
KR20210113271A (ko) * 2019-01-06 2021-09-15 엔도 글로벌 에스테틱스 리미티드 콜라게나제 제형 및 이의 제조 방법
AU2020366008B2 (en) 2019-10-15 2025-08-28 Biospecifics Technologies Corp. Treatment of uterine fibroids using purified collagenase
US20210244642A1 (en) * 2020-02-10 2021-08-12 Simeon Wall, Jr. Cellulite eradication methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US6958150B2 (en) * 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
ATE521355T1 (de) * 2004-05-19 2011-09-15 Los Angeles Biomed Res Inst Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
WO2008101406A1 (en) * 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction

Also Published As

Publication number Publication date
JP2024123126A (ja) 2024-09-10
NZ737403A (en) 2020-05-29
ES2741476T3 (es) 2020-02-11
MX2014004792A (es) 2015-08-14
BR112014009785A2 (pt) 2017-04-25
AU2012325941A1 (en) 2014-05-15
BR112014009785B1 (pt) 2020-06-30
AU2022202987A1 (en) 2022-05-26
AU2020200763B2 (en) 2022-05-26
MX2019007779A (es) 2019-09-04
DK3581199T3 (da) 2023-09-04
US20140335072A1 (en) 2014-11-13
HK1201439A1 (en) 2015-09-04
EP2768523A4 (en) 2015-04-22
US20240216485A1 (en) 2024-07-04
NZ722722A (en) 2019-05-31
EP3581199A1 (en) 2019-12-18
JP2014530873A (ja) 2014-11-20
AU2017248451B2 (en) 2019-11-14
JP2022123073A (ja) 2022-08-23
AU2017248451A1 (en) 2017-11-02
PT3581199T (pt) 2023-08-31
NZ624057A (en) 2016-08-26
PT2768523T (pt) 2019-08-29
AU2022202987B2 (en) 2025-03-20
EP2768523A1 (en) 2014-08-27
JP2020158521A (ja) 2020-10-01
AU2025204462A1 (en) 2025-07-03
DK2768523T3 (da) 2019-07-22
CA2852942C (en) 2023-01-10
PL3581199T3 (pl) 2023-09-11
WO2013059619A1 (en) 2013-04-25
HUE044650T2 (hu) 2019-11-28
CA2852942A1 (en) 2013-04-25
AU2020200763A1 (en) 2020-02-20
EP3581199B1 (en) 2023-05-31
AU2016202026A1 (en) 2016-04-21
NZ759819A (en) 2020-11-27
BR112014009785A8 (pt) 2020-02-27
JP2018027968A (ja) 2018-02-22
NZ769098A (en) 2022-03-25
FI3581199T3 (fi) 2023-08-18
MX392388B (es) 2025-03-24
EP2768523B1 (en) 2019-05-22
ES2953560T3 (es) 2023-11-14

Similar Documents

Publication Publication Date Title
NO2022029I1 (no) eptinezumab/Vyepti®
IL281178B (en) Methods of treating or preventing cholesterol related disorders
HUE036588T2 (hu) Eljárások HCV kezelésére
HUE063599T2 (hu) Eljárások ödémás fibroszklerotikus pannikulopátia kezelésére vagy csökkentésére
EP2740419A4 (en) TREATMENT INSTRUMENT
EP2741703A4 (en) SURGICAL PLIERS
BR112014009795A2 (pt) método
BR112014007958A2 (pt) método
BR112014001765A2 (pt) método
CU24164B1 (es) Inhibidores sustituidos de acetil-coa carboxilasa
BR112014001237A2 (pt) método
CO6890100A2 (es) Tratamientos de combinación para hepatitis c
BR112013012485A2 (pt) método de tratamento com inibidor braf
BR112013016491A2 (pt) método para tratamento de têxtil
EP2785183A4 (en) TRIAZOLPYRIDINON PDE10 INHIBITORS
BR112013022820A2 (pt) método de tratamento
EP2742886A4 (en) SURGICAL SYSTEM
BR112014016108A2 (pt) método de tratamento de perda óssea alvelar
CO6900134A2 (es) Tratamiento de mieloma múltiple
DK2489413T5 (da) Behandlingsapparat
HRP20181399T1 (hr) Postupak za završnu obradu uree
EP2696949A4 (en) BINDING
BR112013023142A2 (pt) método de tratamento de cabelos
PT2750709T (pt) Tratamento da caquexia
EP2606881A4 (en) FAT MEANS